Supernus Pharmaceuticals, Inc.
SUPN
Revenue
211.57M
▲19.47M▲10.13%
3 Months ChangeAssets
1.45B
▲32.89M▲2.32%
3 Months ChangeLiabilities
390.93M
▲20.85M▲5.63%
3 Months ChangeFree Cash Flow
30.27M
▼-7.88M▼-20.66%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-24
Form 8-K
ID: 0001356576-26-000007
2026-02-24
Form 8-K
ID: 0001356576-26-000004
2026-02-12
Form 8-K
ID: 0001356576-26-000002
2026-01-28
Form 8-K
ID: 0001628280-26-003907
2025-11-06
Form 10-Q
ID: 0001356576-25-000071
2025-11-04
Form 8-K
ID: 0001356576-25-000068
2025-10-21
Form 8-K
ID: 0001356576-25-000065
2025-08-05
Form 10-Q
ID: 0001356576-25-000055
2025-08-05
Form 8-K
ID: 0001356576-25-000053
2025-08-04
Form 8-K
ID: 0001356576-25-000050